INVO Bioscience to Present at the August 2020 Lytham Partners Virtual Investor Growth Conference

INVO Bioscience to Present at the August 2020 Lytham Partners Virtual Investor Growth Conference SARASOTA, Fla., Aug. 6, 2020 /PRNewswire/ — INVO Bioscience, Inc. (OTCQB: INVO), (“the Company”, “INVO”) a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world’s only in vivo Intravaginal Culture System, is scheduled to participate in…